Ensign Peak Advisors »

Sage Therapeutics shares owned by Ensign Peak Advisors

Quarter-by-quarter ownership of Sage Therapeutics (SAGE) shares owned by Ensign Peak Advisors from 13F filings

Historical chart of Ensign Peak Advisors investment in Sage Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Sage Therapeutics held by Ensign Peak Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Sage Therapeutics by Ensign Peak Advisors

Quarter filed Position value Share count Share price at filing
2024-12-31 $239k 44k 5.43
2024-09-30 $308k 43k 7.22
2024-06-30 $321k 30k 10.86
2024-03-31 $553k 30k 18.74
2023-09-30 $638k 31k 20.58
2023-06-30 $1.5M 31k 47.02
2023-03-31 $1.3M 31k 41.96
2022-12-31 $1.2M 31k 38.14
2022-09-30 $590k 15k 39.18
2022-06-30 $256k 7.9k 32.24
2022-03-31 $263k 7.9k 33.12
2021-12-31 $338k 7.9k 42.57
2021-09-30 $956k 22k 44.33
2021-06-30 $1.7M 29k 56.80
2021-03-31 $1.5M 21k 74.85
2020-12-31 $2.3M 26k 86.49
2020-09-30 $1.6M 26k 61.11
2020-06-30 $539k 13k 41.51
2020-03-31 $433k 15k 28.68
2019-12-31 $1.4M 19k 72.17